Effects of Antidepressants on Sexual Functioning

• Status: Completed
• Trial end date: 2004-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to study the effects of two depression medications on sexual functioning.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Bupropion

Criteria

Inclusion Criteria:

• Primary diagnosis of Major Depressive Disorder (MDD) with current duration lasting 12 weeks but no greater than 2 years.

• Subjects must engage in sexual activity that leads to orgasm at least once every two weeks.

• Subject must have normal orgasmic function and be willing to discuss with investigator.

Exclusion Criteria:

• Subjects that have arousal or orgasm dysfunction.

• Has previously failed to respond to two adequate trials of antidepressants in past 2 years.

• Subject has other unstable medical disorders.

• Subject has a positive urine test for illicit drug use at screening.